ACOPAIR

Brand name authorized in: Poland United Kingdom

Active ingredients

The drug ACOPAIR contains one active pharmaceutical ingredient (API):

1 Tiotropium bromide
UNII XX112XZP0J - TIOTROPIUM BROMIDE ANHYDROUS

Tiotropium is a long-acting, specific, muscarinic receptor antagonist, in clinical medicine often called an anticholinergic. By binding to the muscarinic receptors in the bronchial smooth musculature, tiotropium inhibits the cholinergic (bronchoconstrictive) effects of acetylcholine, released from parasympathetic nerve endings.

Read about Tiotropium bromide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Tiotropium bromide
R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BB Anticholinergics
Discover more medicines within R03BB04

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 396664, 396665
PL
Rejestru Produktów Leczniczych
Identifier(s): 100389638